Tran‐Der Tan

1.3k total citations
37 papers, 799 citations indexed

About

Tran‐Der Tan is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Tran‐Der Tan has authored 37 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 10 papers in Hematology. Recurrent topics in Tran‐Der Tan's work include Lymphoma Diagnosis and Treatment (11 papers), Head and Neck Cancer Studies (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tran‐Der Tan is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Head and Neck Cancer Studies (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tran‐Der Tan collaborates with scholars based in Taiwan, United States and Singapore. Tran‐Der Tan's co-authors include James Jer‐Min Jian, Skye Hongiun Cheng, Nei‐Min Chu, Stella Y. Tsai, Kwan-Yee Chan, Andrew T. Huang, Kuo‐Yang Yen, Jason Chia‐Hsien Cheng, Mei-Hua Tsou and Szu-Yun Leu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tran‐Der Tan

33 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tran‐Der Tan Taiwan 13 426 371 340 166 106 37 799
Michel Martin France 18 527 1.2× 543 1.5× 383 1.1× 381 2.3× 57 0.5× 32 984
Mei-Hua Tsou Taiwan 16 104 0.2× 177 0.5× 212 0.6× 123 0.7× 104 1.0× 30 552
Carlo Gobitti Italy 16 363 0.9× 369 1.0× 266 0.8× 507 3.1× 73 0.7× 55 994
Sushmita Pathy India 14 93 0.2× 247 0.7× 270 0.8× 275 1.7× 58 0.5× 62 677
P. Bontemps France 10 505 1.2× 297 0.8× 415 1.2× 400 2.4× 96 0.9× 34 1.1k
I. A. Small Brazil 17 210 0.5× 438 1.2× 167 0.5× 626 3.8× 34 0.3× 49 973
Craig Silverman United States 13 508 1.2× 227 0.6× 348 1.0× 344 2.1× 44 0.4× 27 768
Ignacio Azinovic Spain 19 84 0.2× 553 1.5× 401 1.2× 466 2.8× 88 0.8× 57 1.1k
Lionel Duck Belgium 11 64 0.2× 490 1.3× 313 0.9× 279 1.7× 50 0.5× 33 837
Hirohiko Akiyama Japan 20 85 0.2× 311 0.8× 281 0.8× 556 3.3× 54 0.5× 75 1.0k

Countries citing papers authored by Tran‐Der Tan

Since Specialization
Citations

This map shows the geographic impact of Tran‐Der Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tran‐Der Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tran‐Der Tan more than expected).

Fields of papers citing papers by Tran‐Der Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tran‐Der Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tran‐Der Tan. The network helps show where Tran‐Der Tan may publish in the future.

Co-authorship network of co-authors of Tran‐Der Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Tran‐Der Tan. A scholar is included among the top collaborators of Tran‐Der Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tran‐Der Tan. Tran‐Der Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuming, et al.. (2024). Dosing strategy of intrapleural bortezomib for myelomatous pleural effusion: A case report and review of literature. SHILAP Revista de lepidopterología. 5(6). 1325–1329.
3.
Poon, Michelle, Jan Walewski, Isidro Jarque, et al.. (2023). ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2. Hematological Oncology. 41(S2). 141–142. 5 indexed citations
4.
Hsieh, Ching-Yun, Liang‐Tsai Hsiao, Yi‐Chang Liu, et al.. (2022). Stem cell transplant for mantle cell lymphoma in Taiwan. Scientific Reports. 12(1). 5662–5662. 2 indexed citations
5.
Chien, Sheng‐Hsuan, Ming Yao, Chi-Cheng Li, et al.. (2021). Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Journal of the Formosan Medical Association. 120(12). 2144–2152. 7 indexed citations
6.
Tan, Tran‐Der, et al.. (2020). Lenalidomide with Dexamethasone to Multiple Myeloma Patients Relapsing from Bortezomib-Based Induction Therapies. The Chinese Journal of Physiology. 63(5). 211–217. 2 indexed citations
7.
Hsu, Ya‐Ting, Hui‐Jen Tsai, Jeffrey S. Chang, et al.. (2018). Stem cell transplantation for T-cell lymphomas in Taiwan. Bone Marrow Transplantation. 53(8). 993–1000. 3 indexed citations
9.
Hu, Jiong, et al.. (2011). Identification of a novel allele HLA‐DRB1*08:41 in a Chinese donor. Tissue Antigens. 78(4). 294–295. 2 indexed citations
10.
12.
Lee, Ming-Yuan, Tran‐Der Tan, & An‐Chen Feng. (2007). Clinicopathologic Analysis of Acute Myeloid Leukemia in a Single Institution: Biphenotypic Acute Myeloid Leukemia May Not Be an Aggressive Subtype. Journal of the Chinese Medical Association. 70(7). 269–273. 7 indexed citations
13.
Lee, Ming-Yuan, Tran‐Der Tan, An‐Chen Feng, & Mei-Ching Liu. (2006). Clinicopathological analysis of 598 malignant lymphomas in Taiwan: Seven-year experience in a single institution. American Journal of Hematology. 81(8). 568–575. 35 indexed citations
14.
Cheng, Skye Hongiun, Stella Y. Tsai, Kuo‐Yang Yen, et al.. (2005). Prognostic significance of parapharyngeal space venous plexus and marrow involvement: Potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 61(2). 456–465. 46 indexed citations
15.
Chung, Yih‐Lin, James Jer‐Min Jian, Skye Hongiun Cheng, et al.. (2005). Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecologic Oncology. 97(1). 126–135. 62 indexed citations
16.
Tan, Tran‐Der, et al.. (2005). Clinicopathological analysis of T‐cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy‐type intestinal T‐cell lymphoma. European Journal Of Haematology. 75(3). 221–226. 11 indexed citations
17.
Tan, Tran‐Der, et al.. (2005). Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan. Clinical & Laboratory Haematology. 27(6). 379–383. 8 indexed citations
18.
Ong, Yew Kwang, Derrick Heng, Byung Ha Chung, et al.. (2003). Design of a prognostic index score for metastatic nasopharyngeal carcinoma. European Journal of Cancer. 39(11). 1535–1541. 89 indexed citations
19.
Tsou, Mei-Hua, et al.. (1998). Small Cell Carcinoma of the Uterine Cervix with Large Cell Neuroendocrine Carcinoma Component. Gynecologic Oncology. 68(1). 69–72. 20 indexed citations
20.
Cheng, Skye Hongiun, James Jer‐Min Jian, Stella Y. Tsai, et al.. (1998). Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 41(4). 755–762. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026